Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether TissueGene-C, an allogeneic human
chondrocytes expressing Transforming Growth Factor(TGF)-b1, is effective and safe in patients
with degenerative arthritis.